Form 8-K - Current report:
SEC Accession No. 0001193125-24-266141
Filing Date
2024-11-26
Accepted
2024-11-26 16:31:00
Documents
13
Period of Report
2024-11-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d901088d8k.htm   iXBRL 8-K 36384
  Complete submission text file 0001193125-24-266141.txt   162038

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20241125.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20241125_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20241125_pre.xml EX-101.PRE 11256
16 EXTRACTED XBRL INSTANCE DOCUMENT d901088d8k_htm.xml XML 3674
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

EIN.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 241504415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)